Short Talk Presentations
Scientific Program Meeting 2008
Day 1 (15th May 2008)
[PDF-Download]
Short talk presentation:
Therapeutic Vaccination
Chairperson:
S. Grabbe (Mainz), J. Weber (Tampa)
16:30-16:45
P45: DNA fusion gene vaccination, delivered with or without
in vivo electroporation - a potent and safe strategy for
inducing anti-tumor immune responses in prostate cancer
Lindsey Low (Southampton)
16:45-17:00
P10: Immunological and clinical outcome of patients with
acute myeloid leukemia (AML), myelodysplastic syndrome
(MDS), multiple myeloma (MM) and chronic lymphocytic
leukemia (CLL) vaccinated with 300 or
1000 mcg RHAMM-R3 peptide
Michael Schmitt (Ulm)
17:00-17:15
P49: Dynamics of tumor-specific immune responses in
patients affected by metastatic melanoma following
vaccination with autologous lymphocytes genetically modified
to express the MAGE-3 tumor antigen
Raffaella Fontana (Milan)
17:15-17:30
P75: HLA ligands in lung cancer
A. Neumann (Tübingen)
17:30-17:45
P08: Immune response induced by therapeutic vaccination
with epidermal growth factor (EGF) in NSCLC patients
Z. Mazorra (Havana)
Short talk presentation:
Enhancing Immunity and Adjuvants
Chairperson:
P. Brossart (Bonn), K. Thielemans (Brussels)
16:30-16:45
P83: A phase I clinical trial with TriMix-Dendritic cell
vaccine in advanced melanoma patients, preliminary results
Kris Thielemans (Brussels)
16:45-17:00
P22: Recombinant tumor vaccines targeted to CD40 for selective
uptake by professional antigen presenting cells
Ute Burkhardt (Frankfurt)
17:00-17:15
P102
Sebastian Kreiter (Mainz)
17:15-17:30
P56: Preclinical evaluation of novel immunotherapeutic
strategies: Adjuvant administration of TLR-agonists enhances
the therapeutic efficacy of adoptively transferred T cells
against primary cutaneous melanoma in HGF x Cdk4R24C mice
Judith Kohlmeyer (Bonn)
17:30-17:45
PP28: Combining radio- and immunotherapy: The La protein
on irradiated tumor cells as surface target molecule for a
universal immunotherapy
Claudia Franke (Dresden)
17:45-18:00
P15: Phenotypic and functional properties of regulatory
T cells in a mouse model of spontaneous melanoma
Silvia Kimpfler (Heidelberg)
Short talk presentation:
Cellular Therapy
Chairperson:
G. Pawelec (Tübingen), W. Uckert (Berlin)
16:30-16:45
P37: Activated gd T cells- an alternative for antigen
specific immunotherapy?
Silke Landmeier (Münster)
16:45-17:00
P99: Evaluation of engraftment and graft-vs-host reactivity
of ex vivo modified human donor T cell grafts in a chimeric
NOD/SCID/IL2RγcNull transplantation model
Marion Nonn (Mainz)
17:00-17:15
P88: Induction of MAGE-specific donor T-cells for active
immunotherapy in multiple myeloma
Ines Möller (Freiburg)
17:15-17:30
P95: Detection and enrichment of antigen-specific naïve
and effector/memory CD4+ and CD8+ T cells according
to CD137 and CD154 expression
Sonja Schmucker (Tübingen)
17:30-17:45
P61: Reprogramming of bulk T cells with a
tumor-antigen specificity by electroporation of RNA
encoding chimeric T cell receptors
Niels Schaft (Erlangen)
17:45-18:00
P108: Functionality of a human gp100 specific single
chain TCR can be achieved by its partial murinisation
Beate Hauptrock (Mainz)
